Eloxx Pharmaceuticals, Inc. - ELOX
Sector:
Healthcare
· Industry:
Biological Products, (No Diagnostic Substances)
Website:
No information yet
· Social:
No information yet
Company profile
Powered by TradingView
Quarter snapshot
Latest / Compare
Q3 2023
· Q2 2023
Value (USD)
Total reported value ($000)
$1.902M
QoQ value delta ($000)
+$1.428M
(+301.27%)
Implied price effect (QoQ)
+24.34%
Shares
Total shares
396,755
QoQ shares delta
+273,815
(+222.72%)
Total shares held by funds (by quarter)
Market chart (ELOX)
Powered by TradingView
Interactive chart by
TradingView.
Top holders (Q3 2023)
Top 25 only
Full list
Early Q4 2023 data: only 2 institutional holders reported so far. More will appear as funds file with the SEC.
| Manager | Value ($000) | Shares | % of 13F |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 1,322 | 275,000 | 0.02% |
| MENORA MIVTACHIM HOLDINGS LTD. | 251 | 52,355 | 0.0% |
| Altshuler Shaham Ltd | 120 | 25,123 | 0.0% |
| VANGUARD GROUP INC | 99 | 20,786 | 0.0% |
| GEODE CAPITAL MANAGEMENT, LLC | 93 | 19,588 | 0.0% |
| Tower Research Capital LLC (TRC) | 8 | 1,830 | 0.0% |
| WELLS FARGO & COMPANY/MN | 5 | 1,172 | 0.0% |
| ROYAL BANK OF CANADA | 3 | 526 | 0.0% |
| UBS Group AG | 1 | 291 | 0.0% |
| MORGAN STANLEY | 0 | 79 | 0.0% |
| GROUP ONE TRADING, L.P. | 0 | 4 | 0.0% |
| JPMORGAN CHASE & CO | 0 | 1 | 0.0% |